MEDVi vs Strut Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Strut Health beats MEDVi overall, scoring 8.2/10 vs 7.7/10. Strut Health is more affordable at $149/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Strut Health for users who prefer a needle-free oral semaglutide option at a .

A side-by-side look at MEDVi and Strut Health to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Higher Rated

Strut Health

#5 of 52

8.2/10

Oral-focused GLP-1 provider offering needle-free semaglutide options for users who prefer pills over injections.

Visit Strut Health

Feature	MEDVi	Strut Health
Our Score	7.7/10	8.2/10
Starting Price	$179/mo	$149/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Users who prefer a needle-free oral semaglutide option at a reasonable price
Ranking	#20	#5
Get started	Visit MEDVi	Visit Strut Health

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Strut Health

Pros

+Specializes in oral compounded semaglutide, the go-to for patients who absolutely won't do injections
+Needle-free oral semaglutide tablets from $99/mo, one of the lowest oral entry prices in the table, with oral tirzepatide ($199/mo) and auto-refill injectables ($149–$199/mo) if you switch formats
+Clear educational content about oral semaglutide absorption and how to maximize effectiveness
+Simple enrollment: online questionnaire, async provider review, medication shipped to your door

Cons

−Compounded only, no brand-name Wegovy or Zepbound. Oral tablets carry a bioavailability caveat vs injections, so results may come slower on the needle-free formats.
−Oral compounded semaglutide has lower bioavailability than injectable forms, so plan for potentially slower or smaller weight-loss results

Our Verdict

Strut Health edges out MEDVi with a score of 8.2/10 vs 7.7/10. If budget is your priority, Strut Health starts at $149/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Strut Health if you want: users who prefer a needle-free oral semaglutide option at a reasonable price.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither MEDVi nor Strut Health feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review